Cargando…
Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
SIMPLE SUMMARY: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity accounting for ≈5% of all Hodgkin lymphoma (HL) cases. Since pathological characteristics and clinical presentation of NLPHL differ from classical HL and often resemble indolent B-cell non-Hodgkin lymph...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340679/ https://www.ncbi.nlm.nih.gov/pubmed/37444420 http://dx.doi.org/10.3390/cancers15133310 |